Hepion Pharmaceuticals: increases authorized common shares to 750,000,000

What happened Hepion Pharmaceuticals, Inc. filed a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware on Oct 1, 2026. The Certificate of Amendment increased the authorized number of shares of common stock of the Company to 750,000,000 and became effective on filing.

Key details

• Certificate of Amendment filed on Oct 1, 2026 with the Secretary of State of the State of Delaware.
• Increased authorized common stock to 750,000,000 shares.
• The Certificate of Amendment became effective upon filing.

Why it may matter This Item 5.03 report covers amendments to articles of incorporation or bylaws, specifically a change to the company’s authorized common stock. The filing does not show why the insider traded or why the company acted.